George R. Buchanan

TL;DR: Children with sickle cell anemia who have not had a prior severe pneumococcal infection or a splenectomy and are receiving comprehensive care may safely stop prophylactic penicillin therapy at 5 years of age.

TL;DR: The major barrier to marrow transplantation for sickle cell anemia is lack of an HLA-identical donor, and for patients reported to meet eligibility criteria, parental refusal and limited financial or psychosocial support were infrequent barriers to transplantation.

TL;DR: This pilot study suggests that selected children with febrile neutropenia might be successfully managed without hospitalization.

TL;DR: It is difficult to predict which patients are at risk for the development of ICH, and severe hemorrhage is not always curtailed by prior or concomitant therapy.

TL;DR: It is concluded that very high doses of methylprednisolone may induce sustained remission in some patients with transfusion-dependent Diamond-Blackfan anemia refractory to standard-dose prednisone therapy.